Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Novartis AG

Novartis AG (NVS) Stock Overview

Explore Novartis AG’s financial performance, market position, analyst ratings, and future outlook.

NVS●NYSE
HealthcareDrug Manufacturers - General
$145.71
$1.17(0.80%)
U.S. Market opens in 16h 19m

Novartis AG (NVS)

Meyka AI Score

Z

Key Financials

Market Cap276.9B
P/E Ratio22.06
EPS (TTM)$8.69
ROE0.30%
Fundamental Analysis

AI Price Forecasts

1 Month$148.36
3 Months$167.67
1 Year Target$165.70

NVS Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Novartis AG (NYSE: NVS) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Novartis AG's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of NVS on the NYSE shows an RSI of 50.37, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $165.70 for the NYSE listing.

Key metrics behind Novartis AG's NYSE-traded stock include a P/E ratio of 22.06 and a market capitalization of 276.9B. Combined with our AI analysis, these give both institutional and retail investors a clear view of NVS on the NYSE.

Price Performance (NYSE: NVS)

1-Day Change
-0.80%
5-Day Change
1.89%
1-Month Change
-5.27%
3-Month Change
-7.54%
6-Month Change
-1.67%
Year-to-Date (YTD) Change
5.68%
1-Year Change
17.41%
3-Year Change
51.16%
5-Year Change
85.75%
All-Time (Max) Change
826.26%

Contact Information

https://www.novartis.com
41 61 324 1111
Lichtstrasse 35, Basel, BS, 4056

Company Facts

752,670 Employees
IPO DateNov 7, 1996
CountryCH
Actively Trading

Frequently Asked Questions